Skip to main content
Fig. 2 | Arthritis Research & Therapy

Fig. 2

From: High incidence and mortality of Pneumocystis jirovecii infection in anti-MDA5-antibody-positive dermatomyositis: experience from a single center

Fig. 2

The clinical characters and mortality of the PJP cohort. This cohort contains all PJP cases from our center in the recent 3 years. A The distribution of underlying rheumatic diseases in all 30 PJP+ patients in this cohort. B The distribution of rheumatic disease duration at PJP onset. C The mortality of PJP cases in each rheumatic disease. D Comparison of PJP-associated mortality in MDA5+ DM and other rheumatic diseases

Back to article page